OrbiMed Advisors LLC's Form 4 filing
Sionna Therapeutics, Inc. (SION) · filed May 29, 2026
- Accession no.
- 0000947871-26-000587
- Filed
- May 29, 2026, 8:57 PM ET
- Trade date
- May 27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $4.49K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital GP VIII LLCCIK 0001845804 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | SSaleDisposed | −101 | $44.49 | −$4,493.49 | 2,671,721 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.